Alzheimer’s disease and language impairments: social intervention and medical treatment

Communication is very important for people to be successfully integrated into social environment and make and maintain relationship. Particularly, language difficulties lead to social exclusion of the people affected with Alzheimer’s disease (AD) and contribute to a significant decrease in the quality of their life and also have a big impact on their family members who in most cases become their caregivers who need to communicate with their loved ones in order to meet their needs. Therefore, the goal of this study is to describe language impairments in the individual phases of AD and discuss their improvement with respect to AD on the basis of literature review. The authors of this article use traditional research methods in order to achieve the goal set mentioned earlier. First, a method of literature review of available sources describing language impairments in the individual phases of AD is exploited. Second, to show how informal caregivers and relevant drugs can successfully intervene in the improvement of these language impairments, a method of comparison of different research studies exploring such social intervention and medical treatment is used.

[1]  R. Laforce,et al.  [Language deficits in major forms of dementia and primary progressive aphasias: an update according to new diagnostic criteria]. , 2014, Geriatrie et psychologie neuropsychiatrie du vieillissement.

[2]  J. Cummings,et al.  Effect of donepezil on cognition in severe Alzheimer's disease: a pooled data analysis. , 2010, Journal of Alzheimer's disease : JAD.

[3]  C. Beck,et al.  Will a healthy lifestyle help prevent Alzheimer's disease? , 2003, Annual review of public health.

[4]  M. Freedman,et al.  Bilingualism as a protection against the onset of symptoms of dementia , 2007, Neuropsychologia.

[5]  S. Cappa,et al.  The effects of ageing and Alzheimer's disease on semantic and gender priming. , 2004, Brain : a journal of neurology.

[6]  Dr.Lynne Corner Cognitive rehabilitation in dementia , 2002 .

[7]  B. Winblad,et al.  Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials , 2009, Current medical research and opinion.

[8]  Laura Smith-Olinde,et al.  Efficacy of language assessment in Alzheimer’s disease: comparing in-person examination and telemedicine , 2006, Clinical interventions in aging.

[9]  Mustafa Atalay,et al.  Exercise plays a preventive role against Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[10]  C. W. Picanço-Diniz,et al.  CANTAB object recognition and language tests to detect aging cognitive decline: an exploratory comparative study , 2014, Clinical interventions in aging.

[11]  Denise C. Park,et al.  Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.

[12]  J. Olin,et al.  Effects of Oral Rivastigmine on Cognitive Domains in Mild-to-Moderate Alzheimer’s Disease , 2010, American journal of Alzheimer's disease and other dementias.

[13]  R. Ihl,et al.  Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients , 2009, Alzheimer's & Dementia.

[14]  E. Capitani,et al.  Phonetically Cued Word-Fluency, Gender Differences and Aging: A Reappraisal , 1998, Cortex.

[15]  H. Buschke,et al.  Leisure activities and the risk of dementia in the elderly. , 2003, The New England journal of medicine.

[16]  Blanka Klímová,et al.  Alzheimers disease: cost cuts call for novel drugs development and national strategy. , 2015, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti.

[17]  Steven H Ferris,et al.  Language impairment in Alzheimer’s disease and benefits of acetylcholinesterase inhibitors , 2013, Clinical interventions in aging.

[18]  D N Ripich,et al.  Functional Communication with AD Patients: A Caregiver Training Program , 1994, Alzheimer disease and associated disorders.

[19]  T. Fritsch,et al.  Effects of Educational Attainment and Occupational Status on Cognitive and Functional Decline in Persons With Alzheimer-Type Dementia , 2002, International Psychogeriatrics.

[20]  B. Winblad,et al.  Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer's disease--a simulation study. , 2013, Current Alzheimer research.

[21]  F. Schmitt,et al.  Analyzing the impact of 23 mg/day donepezil on language dysfunction in moderate to severe Alzheimer's disease , 2011, Alzheimer's Research & Therapy.

[22]  Sture Eriksson,et al.  Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study , 2006, The Lancet.

[23]  A REVIEW ON ALZHEIMER'S DISEASE: ITS CAUSE, SYMPTOMS,AND TREATMENT AT WORLD WIDE , 2010 .

[24]  Jean-François Dartigues,et al.  The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. , 2005, Brain : a journal of neurology.

[25]  M. Freedman,et al.  Delaying the onset of Alzheimer disease , 2010, Neurology.

[26]  D. Tang‐Wai,et al.  Assessment of Language Function in Dementia , 2022 .

[27]  J. Cooper,et al.  Drug treatment of Alzheimer's disease. , 1991, Archives of internal medicine.

[28]  M. Hofmann,et al.  Advances in Diagnosis and Treatment of Alzheimer's Disease , 2002 .

[29]  S. Chapman,et al.  Evidence-based practice recommendations for dementia: educating caregivers on Alzheimer's disease and training communication strategies , 2007 .

[30]  Y. Stern,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[31]  S. Pekkala,et al.  Semantic Fluency in Mild and Moderate Alzheimer's Disease , 2004 .

[32]  S. E. Black,et al.  Donepezil preserves cognition and global function in patients with severe Alzheimer disease , 2007, Neurology.

[33]  J. Olin,et al.  Reviews: Effects of Transdermal Rivastigmine on ADAS-Cog Items in Mild-to-Moderate Alzheimer’s Disease , 2010, American journal of Alzheimer's disease and other dementias.

[34]  M. Kivipelto,et al.  Alzheimer’s disease — The ways of prevention , 2008, The journal of nutrition, health & aging.

[35]  B. Winblad,et al.  Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.

[36]  Robert A. Israel,et al.  International Classification of Diseases (ICD) , 2005 .

[37]  J. Klimeš,et al.  Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine , 2014, Expert opinion on drug safety.

[38]  A. Wimo,et al.  Safety and efficacy of galantamine (Reminyl) in severe Alzheimer's disease (the SERAD study): a randomised, placebo-controlled, double-blind trial , 2009, The Lancet Neurology.

[39]  M. L. Hummert,et al.  Investigating the effects of communication problems on caregiver burden. , 2005, The journals of gerontology. Series B, Psychological sciences and social sciences.

[40]  I. Lieberburg,et al.  Lethality of Alzheimer Disease and Its Impact on Nursing Home Placement , 2010, Alzheimer disease and associated disorders.

[41]  T. Gale,et al.  ‘Normal’ semantic–phonemic fluency discrepancy in Alzheimer's disease? A meta-analytic study , 2010, Cortex.

[42]  E. Schwam,et al.  Cognition and Function in Alzheimer’s Disease: Identifying the Transitions from Moderate to Severe Disease , 2010, Dementia and Geriatric Cognitive Disorders.

[43]  K. Kuča,et al.  A resurrection of 7-MEOTA: a comparison with tacrine. , 2013, Current Alzheimer research.

[44]  K. Hilari,et al.  What are the important factors in health-related quality of life for people with aphasia? A systematic review. , 2012, Archives of physical medicine and rehabilitation.

[45]  V. Andrisano,et al.  Multitarget drug design strategy: quinone-tacrine hybrids designed to block amyloid-β aggregation and to exert anticholinesterase and antioxidant effects. , 2014, Journal of medicinal chemistry.

[46]  J. Orange,et al.  Enhancing Communication in Dementia of the Alzheimer's Type , 1998 .

[47]  F. Craik,et al.  Bilingualism: consequences for mind and brain , 2012, Trends in Cognitive Sciences.